Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR Newswire —
LOS ANGELES, Nov. 4, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ: JSPR). IF YOU SUFFERED A LOSS ON YOUR JASPER...